Authors:
Tayebi, H
Kuttler, F
Saaa, P
Lienard, A
Petracca, B
Lapierre, V
Ferrand, C
Fest, T
Cahn, JY
Blaise, D
Kuentz, M
Herve, P
Tiberghien, P
Robinet, E
Citation: H. Tayebi et al., Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells, EXP HEMATOL, 29(4), 2001, pp. 458-470
Authors:
Tayebi, H
Tiberghien, P
Ferrand, C
Lienard, A
Duperrier, A
Cahn, JY
Lapierre, V
Saas, P
Kuentz, M
Blaise, D
Herve, P
Robinet, E
Citation: H. Tayebi et al., Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation, BONE MAR TR, 27(2), 2001, pp. 167-175
Authors:
Tayebi, H
Lapierre, V
Saas, P
Lienard, A
Sutton, L
Milpied, N
Attal, M
Cahn, JY
Kuentz, M
Blaise, D
Herve, P
Tiberghien, P
Robinet, E
Citation: H. Tayebi et al., Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft, BR J HAEM, 114(3), 2001, pp. 698-700
Authors:
Lapierre, V
Oubouzar, N
Auperin, A
Tramalloni, D
Tayebi, H
Robinet, E
Kuentz, M
Blaise, D
Hartmann, O
Herve, P
Tiberghien, P
Citation: V. Lapierre et al., Influence of the hematopoietic stem cell source on early immunohematologicreconstitution after allogeneic transplantation, BLOOD, 97(9), 2001, pp. 2580-2586
Authors:
Valteau-Couanet, D
Benhamou, E
Vassal, G
Stambouli, F
Lapierre, V
Couanet, D
Lumbroso, J
Hartmann, O
Citation: D. Valteau-couanet et al., Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma, BONE MAR TR, 25(9), 2000, pp. 937-942
Citation: V. Lapierre et al., Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice, BONE MAR TR, 25(5), 2000, pp. 507-512
Authors:
Lapierre, V
Auperin, A
Benhamou, E
Tursz, T
Citation: V. Lapierre et al., A specific approval procedure for prescribing albumin: Impact on consumption in a cancer treatment institution, ANN ONCOL, 10(2), 1999, pp. 244-245
Citation: V. Lapierre et P. Herve, Transfusion medicine in adults - Labile blood products: preparation and availability, PRESSE MED, 28(24), 1999, pp. 1314-1320
Citation: V. Lapierre et P. Herve, Transfusion medicine in adults - Labile blood products: indications and administration, PRESSE MED, 28(24), 1999, pp. 1321-1326
Citation: V. Lapierre et P. Herve, Transfusion medicine in adults - Monitoring and adverse effects of labile transfusion products, PRESSE MED, 28(24), 1999, pp. 1327-1335
Authors:
Hartmann, O
Valteau-Couanet, D
Vassal, G
Lapierre, V
Brugieres, L
Delgado, R
Couanet, D
Lumbroso, J
Benhamou, E
Citation: O. Hartmann et al., Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution, BONE MAR TR, 23(8), 1999, pp. 789-795